Coronavirus News Roundup: Pfizer Releases More Data on COVID-19 Vaccine

Article

Here’s a roundup of the latest coronavirus-related news.

covid vaccines

Pfizer-BioNTech Releases Newest Topline Data for COVID-19 Vaccine

Pfizer and BioNTech announced topline results from an analysis spanning through March 13, which in part showed their COVID-19 vaccine to be 91.3% effective against the virus for up to 6 months after the second dose.

Read more

Pfizer-BioNTech COVID-19 Vaccine Shows High Efficacy in Adolescents

Pfizer/BioNTech has just released their topline data from their Phase 3 study of participants aged 12 to 15 years.

Read more

Analysis: The Effect of Remote Immunization Screenings on Vaccine Uptake

A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.

Read more

Moderna, Pfizer Vaccines Safe and Effective in Pregnant, Lactating Women

A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.

Read more

Prime Therapeutics Boosts COVID-19 Vax Administration Fees To Match What CMS Is Paying

The Minnesota PBM says it will pay $40 for a single-dose vaccine and $80 for a two-dose one. The company says it has paid pharmacies a total of $29 million in COVID-19 vaccine administration fees so far.

Read more on Managed Healthcare Executive.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Image Credit: tirachard | stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.